The Syndrome of Inappropriate Antidiuretic Hormone (SIADH) is a disease characterized by hyponatremia and hyperosmolality of urine, and where vasopressin, angiotensin II and catecholamines are implicated in salt water balance, cardiovascular and blood pressure regulation. Therefore, the aim of this study is to analyze the hypothalamic distribution of vasopressin (VAS) Angiotensin II (AGII) and tyrosine-hydroxylase (TH) in a case of SIADH and compare it with a case without SIADH. Two hypothalamus taken from a 66 year-old man with SIADH, and the other from a 63 year-old man without SIADH, were used. An immunohistochemical study was performed using anti-VAS, anti-AGII and anti-TH as primary antibodies. The vasopressin immunoreactive material was mainly found in the supraoptic nucleus (SON) and paraventricular nucleus (PVN), but VAS was also shown in the periventricular nucleus, preoptic medial area, perifornical nucleus and hypothalamic lateral area. The AGII was also mainly found in the SON and PVN. The TH was found in the SON, PVN, arcuate nucleus, periventricular nucleus, perifornical nucleus, preoptic medial and lateral area. VAS was less intensive and in a lesser number of cells and fibres in the case of SIADH, as opposed to the AGII and TH which were similar in both cases.
INTRODUCTION
The first case of a patient with the Syndrome of Inappropriate Antidiuretic Hormone (SIADH) was reported by Schwartz et al. [1] who described two patients with lung cancer who developed hyponatremia associated with continuous sodium loss in urine. They postulated that the tumors led to the release of inappropriate antidiuretic hormone (ADH). The clinical description of the syndrome has changed little since the original article, therefore the Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) is a disease characterized by hyponatremia and hyperosmolality of urine [2, 3] . There are well known causes of this syndrome, such as neoplasmatic processes, different disorders of the central nervous system, lung diseases and the side effects of various drugs. Therefore, studies [4] of larger series of patients have revealed that SIADH occurs in 3% of patients with head and neck cancer, in 0.7% of patients with non-small-cell lung cancer, and in 15% of cases of small-cell lung cancer [4] . The optimal therapy for SIADH is to treat the underlying malignant disease. If this is not possible, or if the disease has become refractory, other treatment methods are available such as water restriction, demeclocycline therapy, or, in severe cases, infusion of *Address correspondence to this author at the Departamento de Anatomía, Anatomía Patológica e Histología, Facultad de Medicina, Universidad de La Laguna, 38071 La Laguna, Tenerife, Canary Island, Spain; Tel: 34 922319352; Fax: 34922660253; E-mail: acastane@ull.es hypertonic saline together with furosemide during treatment [4] . Total body water and tonicity is strictly regulated by the renal action of the antidiuretic hormone (ADH), reni angiotensin-aldosterone system, norepinephrine and by the thirst mechanism. Abnormalities in water balance are manifested in SIADH as sodium disturbances-hyponatremia and hypernatremia [4] . On the other hand, the presence of VAS, AGII and TH and their implication in cardiovascular, salt water balance and blood pressure regulation have long been described in the hypothalamus in man and different animal species [5] [6] [7] [8] . Several author have also described the detection of tyrosine hydroxylase-immunoreactivity and vasopressin mRNA and ANGII in the hypothalamus that could be related with the hypertension and SIADH [9] [10] [11] [12] . The aim of the present work is to analyze the hypothalamic distribution of vasopressin (VAS), AGII and Tyrosinehydroxylase (TH) in a case of SIADH.
CASE REPORT
Two hypothalamus taken from two human brains from the collection of the Anatomy Department of the University of La Laguna were studied here. A 66 year old man that had developed hyponatremia and showed all the symptoms of the Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH), and the other subject was a 63 year old man without SIADH as a control. Non-small-cell lung cancer was the cause of death in the SIADH case, in the other case the underlying disease was cardioangioesclerosis and the patient died of multi-organ failure. The hypothalamus were cut in four series of coronal sections 10 μm thick. The A series was stained with the Klüver-Barrier method. The B, C and D series were processed immunohistochemically; antivasopressin (VAS) (ICN Biomedicals, Inc. Catal.6#:4717), anti-angiotensin II (AGII) [7] and anti-TyrosineHydroxylase (TH)(SIGMA, T 2928) were used as primary antibodies. The anti-VAS, the anti-AGII and the anti-TH were diluted at 1:2000, 1:100 and 1:1000 respectively in PBS-Triton with 2% normal goat serum, the incubation was for 24 h, at room temperature. Followed by "DAKO StreptABCcomplex/HRP Duet, Mouse/Rabbit" procedure. The reaction product was visualized by diaminobenzidine reaction. Method specificity was controlled by omitting the primary antibody.
The immunohistochemistry slides were converted to digital images by using an LEICA DMRB photomicroscope with an LEICA DC 300 F camera (Gemany). Image analysis was completed in Image J (v. 1.43 u, NIH, Bethesda, MD, USA). The 'Mean Gray Value' was measured from the selected nuclei for all stained tissue. This value gives the average stain intensity in grayscale units for all threshold pixels. A single-factor analysis of variance (ANOVA) was used for the immunohistochemistry statistical study, which was conducted using the IBM SPSS statistic 19 software.
The vasopressin immunoreactive material (VAS-ir) was mainly found in both cases (Figs. 1, 2 ) in the rostral, intermediate and caudal part of the supraoptic hypothalamic nucleus and magnocellular part of the entering paraventricular hypothalamic nucleus, but VAS-ir was also shown in the periventricular nucleus, preoptic medial area, perifornical nucleus, and the caudal part of the hypothalamic lateral area. The AGII-ir was found (Fig. 3) in similar locations as VAS, but mainly in neurons of the SON and magnocellular part of the PVN. The tyrosine-hydroxylase immunoreactive (TH-ir) was found in SON and in PVN (Fig.  4) , and also in the arcuate nucleus, periventricular nucleus, perifornical nucleus, preoptic medial and lateral area. TH-ir was higher in the PVN with respect to the SON.
VAS-ir (Graphs 1 and 2) was clearly decreased and in a smaller number of cells and fibres in SIADH, as opposed to the intensity of AGII-ir and TH-ir which were similar in both cases (Graphs 1 and 2) but TH-ir was clearly greater in both cases in the PVN with respect to the SON (Graph 3). 
DISCUSSION
The Syndrome of Inappropriate Antidiuretic Hormone Secretion or Syndrome of Inappropriate Antidiuresis, is apparently induced by an extensive range of diseases, drugs, and/or injuries and is divisible into 3 kinds of abnormal vasopressin (VAS) release during hypertonic saline infusion [13] : type A, elevated, inconsistent fluctuations unrelated to increases in plasma sodium; type B, a slow regular release, that is also unaltered by increases in plasma sodium; type C, a quick progressive increase in plasma VAS that closely correlates with plasma sodium as it rises towards the normal range; there is also another kind, type D, that appears in a low percentage of patients, where there is no demonstrable defect in the osmoregulation of AVP and the cause of inappropriate antidiuresis is imprecise [13, 14] . The case presented in this paper could correspond to SIADH type C described above [13, 14] , because the patient periodically showed a progressive increase in plasma vasopressin that closely correlated with increased plasma sodium, and at other times the patient showed normal or decreased levels of VAS that corresponded to normal or decreased levels of plasma sodium.
On the other hand, several authors [14] have reported that the pathophysiological basis of SIADH is an absolute increase in body water. This increase depends on an excessive water intake that overwhelms the restricted renal ability of diluting urine and mounting compensatory dieresis due to vasopressin dysregulation, in agreement with this, the vasopressin immunoreactive material, in the present study, was less intensive and in a lesser number of cells and fibres in the SIADH and was mainly found in the whole supraoptic nucleus and magnocellular part of the paraventricular hypothalamic nucleus. Vasopressin was also observed in the other hypothalamic areas. The decrease of VAS in the case of SIADH could mean an increase of the VAS release owing to variations in the vasopressin receptor, since other studies [15] have described some cases, whose clinical presentation and laboratory findings were consistent with SIADH, but which exhibited unmeasurable arginine-vasopressin (AVP) levels on repeated occasions that appears to be due to an activating mutation of the vasopressin receptor V2 (V2R). But, in other patients, this may be due to abnormal control of aquaporin-2 water channels in renal collecting tubules or the production of an antidiuretic principle other than VAS [13] .
In conclusion, no differences in the AGII-ir and TH-ir intensity and location expression between both cases were found in the results here and only a decrease of VAS in both the paraventricular and supraoptic nucleus was observed, which could mean a lesser participation of TH and AGII than VAS in the physiopathology of the SIADH. These disparate kinds of results underlying SIADH may result in clear differences in its clinical presentation as well as its response to different kinds of treatment.
